首页 > 市场调查报告书 > 製药

医药品法规环境

市场调查报告书

商品编码

1378941

药物警戒市场：2023-2028 年全球产业趋势、份额、规模、成长、机会与预测

Pharmacovigilance Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

出版日期: 2023年11月02日 | 出版商:

IMARC | 英文 147 Pages | 商品交期: 2-3个工作天内

价格

简介目录图表

抽象的

2022年全球药物警戒市场规模达73亿美元。展望未来， IMARC Group预计到2028年市场规模将达到121亿美元，2022-2028年复合年增长率（CAGR）为8.8%。

药物警戒（PV）是涉及检测、评估、了解和预防药物不良反应的药理科学。它在识别以前未知的不良反应、识别频率或严重程度的变化以及评估药物的风险和益处以确定所需的行动方面发挥关键作用。它还确保向医疗保健专业人员和患者传达的讯息的准确性。目前，PV 被广泛用于了解药物对全世界个体的影响。

药物警戒市场趋势：

高血压、糖尿病和心臟病等生活方式疾病的盛行率不断上升，导致全球药物消费量不断增加。这与不断增加的药物不良反应 (ADR) 发生率相结合，是推动全球药物警戒市场的关键因素之一。除此之外，主要参与者正在引入先进的平台来确保自动 ADR 报告，这有助于市场成长。鑑于竞争环境，他们也专注于改善製造营运并简化研发 (R&D)。此外，领先的製药公司正在采取许多倡议来进行临床试验并提高人们对正确使用药物的认识。这反过来又促进了药物警戒市场的成长。此外，冠状病毒病（COVID-19）的爆发导致对疫苗的迫切需求，这为市场参与者创造了众多机会。除此之外，考虑到相关的好处，例如提高内部资源灵活性和在更短的时间内获得更好的结果，药厂正在转向将药物警戒业务外包给第三方。

本报告回答的关键问题：

迄今为止，全球药物警戒市场的表现如何，未来几年将如何表现？
COVID-19 对全球药物警戒市场有何影响？
主要区域市场有哪些？
基于服务提供者的市场区隔是什么？
基于产品生命週期的市场区隔是怎样的？
依类型划分市场是怎么样的？
根据流程划分市场是怎么样的？
基于治疗领域的市场区隔是什么？
根据最终用途分類的市场是怎样的？
产业价值链的各个阶段是什么？
该行业的关键驱动因素和挑战是什么？
全球药物警戒市场的结构如何？谁是主要参与者？
产业竞争程度如何？

案例资料管理
- 市场走向
- 主要类型
  - 案例记录
  - 案例数据分析
  - 医学审查和报告
- 市场预测
讯号检测
- 市场走向
- 主要类型
  - 不良事件记录
  - 不良事件分析
  - 不良事件审查和报告
- 市场预测
风险管理系统
- 市场走向
- 主要类型
  - 风险评估体系
  - 风险缓释系统
- 市场预测

第 10 章：按治疗领域分類的市场细分

肿瘤学
- 市场走向
- 市场预测
神经病学
- 市场走向
- 市场预测
心臟病学
- 市场走向
- 市场预测
呼吸系统
- 市场走向
- 市场预测
其他的
- 市场走向
- 市场预测

第 11 章：依最终用途分類的市场细分

製药公司
- 市场走向
- 市场预测
生技公司
- 市场走向
- 市场预测
医疗器材公司
- 市场走向
- 市场预测
其他的
- 市场走向
- 市场预测

第 12 章：按地区分類的市场细分

北美洲
- 美国
  - 市场走向
  - 市场预测
- 加拿大
  - 市场走向
  - 市场预测
亚太
- 中国
  - 市场走向
  - 市场预测
- 日本
  - 市场走向
  - 市场预测
- 印度
  - 市场走向
  - 市场预测
- 韩国
  - 市场走向
  - 市场预测
- 澳洲
  - 市场走向
  - 市场预测
- 印尼
  - 市场走向
  - 市场预测
- 其他的
  - 市场走向
  - 市场预测
欧洲
- 德国
  - 市场走向
  - 市场预测
- 法国
  - 市场走向
  - 市场预测
- 英国
  - 市场走向
  - 市场预测
- 义大利
  - 市场走向
  - 市场预测
- 西班牙
  - 市场走向
  - 市场预测
- 俄罗斯
  - 市场走向
  - 市场预测
- 其他的
  - 市场走向
  - 市场预测
拉丁美洲
- 巴西
  - 市场走向
  - 市场预测
- 墨西哥
  - 市场走向
  - 市场预测
- 其他的
  - 市场走向
  - 市场预测
中东和非洲
- 市场走向
- 按国家/地区分類的市场细分
- 市场预测

第 13 章：SWOT 分析

概述
优势
弱点
机会
威胁

第 14 章：价值链分析

第 15 章：波特五力分析

概述
买家的议价能力
供应商的议价能力
竞争程度
新进入者的威胁
替代品的威胁

第 16 章：价格分析

第17章：竞争格局

市场结构
关键参与者
关键参与者简介
- Accenture plc
- ArisGlobal LLC
- BioClinica Inc. (Cinven Partners LLP)
- Capgemini
- Cognizant
- International Business Machines Corporation
- ICON plc.
- IQVIA Inc.
- ITClinical
- Parexel International Corporation
- Wipro Limited

简介目录图表

Product Code: SR112023A3609

Abstract

The global pharmacovigilance market size reached US$ 7.3 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 12.1 Billion by 2028, exhibiting a growth rate (CAGR) of 8.8% during 2022-2028.

Pharmacovigilance (PV) is the pharmacological science concerning the detection, assessment, understanding and prevention of unfavorable effects with pharmaceutical products. It plays a pivotal role in identifying previously unknown adverse effects, recognizing changes in the frequency or severity, and assessing the risks and benefits of drugs to determine required actions. It also ensures the accuracy of communicated information to healthcare professionals and patients. At present, PV is widely used to understand the effects of drugs on individuals worldwide.

Pharmacovigilance Market Trends:

The increasing prevalence of lifestyle diseases, such as hypertension, diabetes, and cardiac disorders, has resulted in the rising consumption of drugs worldwide. This, in confluence with the growing incidences of adverse drug reactions (ADRs), represents one of the key factors driving the global pharmacovigilance market. Besides this, the key players are introducing advanced platforms to ensure automated ADR reporting, which is contributing to the market growth. They are also focusing on improving the manufacturing operations and streamlining research and development (R&D) on account of a competitive environment. Furthermore, leading pharmaceutical companies are undertaking numerous initiatives to conduct clinical trials and generate awareness about the proper utilization of medicines. This, in turn, is facilitating the growth of the pharmacovigilance market. Additionally, the coronavirus disease (COVID-19) outbreak has resulted in the urgent need for a vaccine, which has created numerous opportunities for the market players. Apart from this, pharmaceutical manufacturers are shifting towards outsourcing pharmacovigilance operations to third parties on account of the associated benefits, such as increasing internal resource flexibility and better outcomes over shorter periods.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global pharmacovigilance market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on service provider, product life cycle, type, process flow, therapeutic area and end use.

Breakup by Service Provider:

In-house

Contract Outsourcing

Breakup by Product Life Cycle:

Pre-clinical

Phase I

Phase II

Phase III

Phase IV

Breakup by Type:

Spontaneous Reporting

Intensified ADR Reporting

Targeted Spontaneous Reporting

Cohort Event Monitoring

EHR Mining

Breakup by Process Flow:

Case Data Management

Case Logging

Case Data Analysis

Medical Reviewing and Reporting

Signal Detection

Adverse Event Logging

Adverse Event Analysis

Adverse Event Review and Reporting

Risk Management System

Risk Evaluation System

Risk Mitigation System

Breakup by Therapeutic Area:

Oncology

Neurology

Cardiology

Respiratory Systems

Others

Breakup by End Use:

Pharmaceuticals Companies

Biotechnology Companies

Medical Device Companies

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Accenture plc, ArisGlobal LLC, BioClinica Inc. (Cinven Partners LLP), Capgemini, Cognizant, International Business Machines Corporation, ICON plc., IQVIA Inc., ITClinical, Parexel International Corporation and Wipro Limited.

Key Questions Answered in This Report:

How has the global pharmacovigilance market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global pharmacovigilance market?
What are the key regional markets?
What is the breakup of the market based on the service provider?
What is the breakup of the market based on the product life cycle?
What is the breakup of the market based on the type?
What is the breakup of the market based on the process flow?
What is the breakup of the market based on the therapeutic area?
What is the breakup of the market based on the end use?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global pharmacovigilance market and who are the key players?
What is the degree of competition in the industry?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Pharmacovigilance Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Service Provider

6.1 In-house
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
6.2 Contract Outsourcing
- 6.2.1 Market Trends
- 6.2.2 Market Forecast

7 Market Breakup by Product Life Cycle

7.1 Pre-clinical
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 Phase I
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
7.3 Phase II
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
7.4 Phase III
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
7.5 Phase IV
- 7.5.1 Market Trends
- 7.5.2 Market Forecast

8 Market Breakup by Type

8.1 Spontaneous Reporting
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
8.2 Intensified ADR Reporting
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
8.3 Targeted Spontaneous Reporting
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
8.4 Cohort Event Monitoring
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
8.5 EHR Mining
- 8.5.1 Market Trends
- 8.5.2 Market Forecast

9 Market Breakup by Process Flow

9.1 Case Data Management
- 9.1.1 Market Trends
- 9.1.2 Major Types
  - 9.1.2.1 Case Logging
  - 9.1.2.2 Case Data Analysis
  - 9.1.2.3 Medical Reviewing and Reporting
- 9.1.3 Market Forecast
9.2 Signal Detection
- 9.2.1 Market Trends
- 9.2.2 Major Types
  - 9.2.2.1 Adverse Event Logging
  - 9.2.2.2 Adverse Event Analysis
  - 9.2.2.3 Adverse Event Review and Reporting
- 9.2.3 Market Forecast
9.3 Risk Management System
- 9.3.1 Market Trends
- 9.3.2 Major Types
  - 9.3.2.1 Risk Evaluation System
  - 9.3.2.2 Risk Mitigation System
- 9.3.3 Market Forecast

10 Market Breakup by Therapeutic Area

10.1 Oncology
- 10.1.1 Market Trends
- 10.1.2 Market Forecast
10.2 Neurology
- 10.2.1 Market Trends
- 10.2.2 Market Forecast
10.3 Cardiology
- 10.3.1 Market Trends
- 10.3.2 Market Forecast
10.4 Respiratory Systems
- 10.4.1 Market Trends
- 10.4.2 Market Forecast
10.5 Others
- 10.5.1 Market Trends
- 10.5.2 Market Forecast

11 Market Breakup by End Use

11.1 Pharmaceuticals Companies
- 11.1.1 Market Trends
- 11.1.2 Market Forecast
11.2 Biotechnology Companies
- 11.2.1 Market Trends
- 11.2.2 Market Forecast
11.3 Medical Device Companies
- 11.3.1 Market Trends
- 11.3.2 Market Forecast
11.4 Others
- 11.4.1 Market Trends
- 11.4.2 Market Forecast

12 Market Breakup by Region

12.1 North America
- 12.1.1 United States
  - 12.1.1.1 Market Trends
  - 12.1.1.2 Market Forecast
- 12.1.2 Canada
  - 12.1.2.1 Market Trends
  - 12.1.2.2 Market Forecast
12.2 Asia-Pacific
- 12.2.1 China
  - 12.2.1.1 Market Trends
  - 12.2.1.2 Market Forecast
- 12.2.2 Japan
  - 12.2.2.1 Market Trends
  - 12.2.2.2 Market Forecast
- 12.2.3 India
  - 12.2.3.1 Market Trends
  - 12.2.3.2 Market Forecast
- 12.2.4 South Korea
  - 12.2.4.1 Market Trends
  - 12.2.4.2 Market Forecast
- 12.2.5 Australia
  - 12.2.5.1 Market Trends
  - 12.2.5.2 Market Forecast
- 12.2.6 Indonesia
  - 12.2.6.1 Market Trends
  - 12.2.6.2 Market Forecast
- 12.2.7 Others
  - 12.2.7.1 Market Trends
  - 12.2.7.2 Market Forecast
12.3 Europe
- 12.3.1 Germany
  - 12.3.1.1 Market Trends
  - 12.3.1.2 Market Forecast
- 12.3.2 France
  - 12.3.2.1 Market Trends
  - 12.3.2.2 Market Forecast
- 12.3.3 United Kingdom
  - 12.3.3.1 Market Trends
  - 12.3.3.2 Market Forecast
- 12.3.4 Italy
  - 12.3.4.1 Market Trends
  - 12.3.4.2 Market Forecast
- 12.3.5 Spain
  - 12.3.5.1 Market Trends
  - 12.3.5.2 Market Forecast
- 12.3.6 Russia
  - 12.3.6.1 Market Trends
  - 12.3.6.2 Market Forecast
- 12.3.7 Others
  - 12.3.7.1 Market Trends
  - 12.3.7.2 Market Forecast
12.4 Latin America
- 12.4.1 Brazil
  - 12.4.1.1 Market Trends
  - 12.4.1.2 Market Forecast
- 12.4.2 Mexico
  - 12.4.2.1 Market Trends
  - 12.4.2.2 Market Forecast
- 12.4.3 Others
  - 12.4.3.1 Market Trends
  - 12.4.3.2 Market Forecast
12.5 Middle East and Africa
- 12.5.1 Market Trends
- 12.5.2 Market Breakup by Country
- 12.5.3 Market Forecast

13 SWOT Analysis

13.1 Overview
13.2 Strengths
13.3 Weaknesses
13.4 Opportunities
13.5 Threats

14 Value Chain Analysis

15 Porters Five Forces Analysis

15.1 Overview
15.2 Bargaining Power of Buyers
15.3 Bargaining Power of Suppliers
15.4 Degree of Competition
15.5 Threat of New Entrants
15.6 Threat of Substitutes

16 Price Analysis

17 Competitive Landscape

17.1 Market Structure
17.2 Key Players
17.3 Profiles of Key Players
- 17.3.1 Accenture plc
  - 17.3.1.1 Company Overview
  - 17.3.1.2 Product Portfolio
  - 17.3.1.3 Financials
  - 17.3.1.4 SWOT Analysis
- 17.3.2 ArisGlobal LLC
  - 17.3.2.1 Company Overview
  - 17.3.2.2 Product Portfolio
- 17.3.3 BioClinica Inc. (Cinven Partners LLP)
  - 17.3.3.1 Company Overview
  - 17.3.3.2 Product Portfolio
  - 17.3.3.3 SWOT Analysis
- 17.3.4 Capgemini
  - 17.3.4.1 Company Overview
  - 17.3.4.2 Product Portfolio
- 17.3.5 Cognizant
  - 17.3.5.1 Company Overview
  - 17.3.5.2 Product Portfolio
  - 17.3.5.3 Financials
  - 17.3.5.4 SWOT Analysis
- 17.3.6 International Business Machines Corporation
  - 17.3.6.1 Company Overview
  - 17.3.6.2 Product Portfolio
  - 17.3.6.3 Financials
  - 17.3.6.4 SWOT Analysis
- 17.3.7 ICON plc.
  - 17.3.7.1 Company Overview
  - 17.3.7.2 Product Portfolio
  - 17.3.7.3 Financials
  - 17.3.7.4 SWOT Analysis
- 17.3.8 IQVIA Inc.
  - 17.3.8.1 Company Overview
  - 17.3.8.2 Product Portfolio
  - 17.3.8.3 Financials
  - 17.3.8.4 SWOT Analysis
- 17.3.9 ITClinical
  - 17.3.9.1 Company Overview
  - 17.3.9.2 Product Portfolio
- 17.3.10 Parexel International Corporation
  - 17.3.10.1 Company Overview
  - 17.3.10.2 Product Portfolio
  - 17.3.10.3 SWOT Analysis
- 17.3.11 Wipro Limited
  - 17.3.11.1 Company Overview
  - 17.3.11.2 Product Portfolio
  - 17.3.11.3 Financials
  - 17.3.11.4 SWOT Analysis

简介目录图表

List of Figures

Figure 1: Global: Pharmacovigilance Market: Major Drivers and Challenges
Figure 2: Global: Pharmacovigilance Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Pharmacovigilance Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 4: Global: Pharmacovigilance Market: Breakup by Service Provider (in %), 2022
Figure 5: Global: Pharmacovigilance Market: Breakup by Product Life Cycle (in %), 2022
Figure 6: Global: Pharmacovigilance Market: Breakup by Type (in %), 2022
Figure 7: Global: Pharmacovigilance Market: Breakup by Process Flow (in %), 2022
Figure 8: Global: Pharmacovigilance Market: Breakup by Therapeutic Area (in %), 2022
Figure 9: Global: Pharmacovigilance Market: Breakup by End Use (in %), 2022
Figure 10: Global: Pharmacovigilance Market: Breakup by Region (in %), 2022
Figure 11: Global: Pharmacovigilance (In-house) Market: Sales Value (in Million US$), 2017 & 2022
Figure 12: Global: Pharmacovigilance (In-house) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 13: Global: Pharmacovigilance (Contract Outsourcing) Market: Sales Value (in Million US$), 2017 & 2022
Figure 14: Global: Pharmacovigilance (Contract Outsourcing) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 15: Global: Pharmacovigilance (Pre-clinical) Market: Sales Value (in Million US$), 2017 & 2022
Figure 16: Global: Pharmacovigilance (Pre-clinical) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 17: Global: Pharmacovigilance (Phase I) Market: Sales Value (in Million US$), 2017 & 2022
Figure 18: Global: Pharmacovigilance (Phase I) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 19: Global: Pharmacovigilance (Phase II) Market: Sales Value (in Million US$), 2017 & 2022
Figure 20: Global: Pharmacovigilance (Phase II) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 21: Global: Pharmacovigilance (Phase III) Market: Sales Value (in Million US$), 2017 & 2022
Figure 22: Global: Pharmacovigilance (Phase III) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 23: Global: Pharmacovigilance (Phase IV) Market: Sales Value (in Million US$), 2017 & 2022
Figure 24: Global: Pharmacovigilance (Phase IV) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 25: Global: Pharmacovigilance (Spontaneous Reporting) Market: Sales Value (in Million US$), 2017 & 2022
Figure 26: Global: Pharmacovigilance (Spontaneous Reporting) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 27: Global: Pharmacovigilance (Intensified ADR Reporting) Market: Sales Value (in Million US$), 2017 & 2022
Figure 28: Global: Pharmacovigilance (Intensified ADR Reporting) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 29: Global: Pharmacovigilance (Targeted Spontaneous Reporting) Market: Sales Value (in Million US$), 2017 & 2022
Figure 30: Global: Pharmacovigilance (Targeted Spontaneous Reporting) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 31: Global: Pharmacovigilance (Cohort Event Monitoring) Market: Sales Value (in Million US$), 2017 & 2022
Figure 32: Global: Pharmacovigilance (Cohort Event Monitoring) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 33: Global: Pharmacovigilance (EHR Mining) Market: Sales Value (in Million US$), 2017 & 2022
Figure 34: Global: Pharmacovigilance (EHR Mining) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 35: Global: Pharmacovigilance (Case Data Management) Market: Sales Value (in Million US$), 2017 & 2022
Figure 36: Global: Pharmacovigilance (Case Data Management) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 37: Global: Pharmacovigilance (Signal Detection) Market: Sales Value (in Million US$), 2017 & 2022
Figure 38: Global: Pharmacovigilance (Signal Detection) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 39: Global: Pharmacovigilance (Risk Management System) Market: Sales Value (in Million US$), 2017 & 2022
Figure 40: Global: Pharmacovigilance (Risk Management System) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 41: Global: Pharmacovigilance (Oncology) Market: Sales Value (in Million US$), 2017 & 2022
Figure 42: Global: Pharmacovigilance (Oncology) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 43: Global: Pharmacovigilance (Neurology) Market: Sales Value (in Million US$), 2017 & 2022
Figure 44: Global: Pharmacovigilance (Neurology) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 45: Global: Pharmacovigilance (Cardiology) Market: Sales Value (in Million US$), 2017 & 2022
Figure 46: Global: Pharmacovigilance (Cardiology) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 47: Global: Pharmacovigilance (Respiratory Systems) Market: Sales Value (in Million US$), 2017 & 2022
Figure 48: Global: Pharmacovigilance (Respiratory Systems) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 49: Global: Pharmacovigilance (Other Therapeutic Areas) Market: Sales Value (in Million US$), 2017 & 2022
Figure 50: Global: Pharmacovigilance (Other Therapeutic Areas) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 51: Global: Pharmacovigilance (Pharmaceuticals Companies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 52: Global: Pharmacovigilance (Pharmaceuticals Companies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 53: Global: Pharmacovigilance (Biotechnology Companies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 54: Global: Pharmacovigilance (Biotechnology Companies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 55: Global: Pharmacovigilance (Medical Device Companies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 56: Global: Pharmacovigilance (Medical Device Companies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 57: Global: Pharmacovigilance (Other End Uses) Market: Sales Value (in Million US$), 2017 & 2022
Figure 58: Global: Pharmacovigilance (Other End Uses) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 59: North America: Pharmacovigilance Market: Sales Value (in Million US$), 2017 & 2022
Figure 60: North America: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 61: United States: Pharmacovigilance Market: Sales Value (in Million US$), 2017 & 2022
Figure 62: United States: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 63: Canada: Pharmacovigilance Market: Sales Value (in Million US$), 2017 & 2022
Figure 64: Canada: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 65: Asia-Pacific: Pharmacovigilance Market: Sales Value (in Million US$), 2017 & 2022
Figure 66: Asia-Pacific: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 67: China: Pharmacovigilance Market: Sales Value (in Million US$), 2017 & 2022
Figure 68: China: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 69: Japan: Pharmacovigilance Market: Sales Value (in Million US$), 2017 & 2022
Figure 70: Japan: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 71: India: Pharmacovigilance Market: Sales Value (in Million US$), 2017 & 2022
Figure 72: India: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 73: South Korea: Pharmacovigilance Market: Sales Value (in Million US$), 2017 & 2022
Figure 74: South Korea: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 75: Australia: Pharmacovigilance Market: Sales Value (in Million US$), 2017 & 2022
Figure 76: Australia: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 77: Indonesia: Pharmacovigilance Market: Sales Value (in Million US$), 2017 & 2022
Figure 78: Indonesia: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 79: Others: Pharmacovigilance Market: Sales Value (in Million US$), 2017 & 2022
Figure 80: Others: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 81: Europe: Pharmacovigilance Market: Sales Value (in Million US$), 2017 & 2022
Figure 82: Europe: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 83: Germany: Pharmacovigilance Market: Sales Value (in Million US$), 2017 & 2022
Figure 84: Germany: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 85: France: Pharmacovigilance Market: Sales Value (in Million US$), 2017 & 2022
Figure 86: France: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 87: United Kingdom: Pharmacovigilance Market: Sales Value (in Million US$), 2017 & 2022
Figure 88: United Kingdom: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 89: Italy: Pharmacovigilance Market: Sales Value (in Million US$), 2017 & 2022
Figure 90: Italy: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 91: Spain: Pharmacovigilance Market: Sales Value (in Million US$), 2017 & 2022
Figure 92: Spain: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 93: Russia: Pharmacovigilance Market: Sales Value (in Million US$), 2017 & 2022
Figure 94: Russia: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 95: Others: Pharmacovigilance Market: Sales Value (in Million US$), 2017 & 2022
Figure 96: Others: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 97: Latin America: Pharmacovigilance Market: Sales Value (in Million US$), 2017 & 2022
Figure 98: Latin America: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 99: Brazil: Pharmacovigilance Market: Sales Value (in Million US$), 2017 & 2022
Figure 100: Brazil: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 101: Mexico: Pharmacovigilance Market: Sales Value (in Million US$), 2017 & 2022
Figure 102: Mexico: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 103: Others: Pharmacovigilance Market: Sales Value (in Million US$), 2017 & 2022
Figure 104: Others: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 105: Middle East and Africa: Pharmacovigilance Market: Sales Value (in Million US$), 2017 & 2022
Figure 106: Middle East and Africa: Pharmacovigilance Market: Breakup by Country (in %), 2022
Figure 107: Middle East and Africa: Pharmacovigilance Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 108: Global: Pharmacovigilance Industry: SWOT Analysis
Figure 109: Global: Pharmacovigilance Industry: Value Chain Analysis
Figure 110: Global: Pharmacovigilance Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Pharmacovigilance Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Pharmacovigilance Market Forecast: Breakup by Service Provider (in Million US$), 2023-2028
Table 3: Global: Pharmacovigilance Market Forecast: Breakup by Product Life Cycle (in Million US$), 2023-2028
Table 4: Global: Pharmacovigilance Market Forecast: Breakup by Type (in Million US$), 2023-2028
Table 5: Global: Pharmacovigilance Market Forecast: Breakup by Process Flow (in Million US$), 2023-2028
Table 6: Global: Pharmacovigilance Market Forecast: Breakup by Therapeutic Area (in Million US$), 2023-2028
Table 7: Global: Pharmacovigilance Market Forecast: Breakup by End Use (in Million US$), 2023-2028
Table 8: Global: Pharmacovigilance Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 9: Global: Pharmacovigilance Market: Competitive Structure
Table 10: Global: Pharmacovigilance Market: Key Players

02-2729-4219

+886-2-2729-4219